Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
JAMA
|
June 16, 2011
Shadowing physicians
Kenneth R Wong, Jessica A Gold
JAMA
|
July 12, 2012
Shortening medical education
Jessica A Gold, Kenneth R Wong
Plastic and Reconstructive Surgery
|
January 30, 2013
Bilateral bookend pericranial flaps
Kenneth R Wong, John H Phillips, Derek M Steinbacher
Biochimie
|
November 8, 2015
In vivo imaging of protease activity by Probody therapeutic activation
Kenneth R Wong, Elizabeth Menendez, Charles S Craik, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
August 25, 2012
A range of malar and masseteric hypoplasia exists in Treacher Collins syndrome
Kenneth R Wong, Miles J Pfaff, Christopher C Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Science Translational Medicine
|
October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index
Luc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
JAMA
|
June 16, 2011
Shadowing physicians
Kenneth R Wong, Jessica A Gold
JAMA
|
July 12, 2012
Shortening medical education
Jessica A Gold, Kenneth R Wong
Plastic and Reconstructive Surgery
|
January 30, 2013
Bilateral bookend pericranial flaps
Kenneth R Wong, John H Phillips, Derek M Steinbacher
Biochimie
|
November 8, 2015
In vivo imaging of protease activity by Probody therapeutic activation
Kenneth R Wong, Elizabeth Menendez, Charles S Craik, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
|
August 25, 2012
A range of malar and masseteric hypoplasia exists in Treacher Collins syndrome
Kenneth R Wong, Miles J Pfaff, Christopher C Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia
Sampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.
Science Translational Medicine
|
October 18, 2013
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index
Luc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, et al.
Page
of 1